Residue 81 confers a restricted C-terminal peptide binding motif in HLA-B*44:09

Immunogenetics

Volumn 64, Issue 9, 2012, Pages 663-668

  Huyton, Trevor ^a   Schumacher, Heike ^a   Blasczyk, Rainer ^a   Bade Doeding, Christina ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Auxiliary anchor; Peptide binding motif; Polymorphism; Stem cell transplantation

Indexed keywords

AMINO ACID; CARBOXY TERMINAL TELOPEPTIDE; HLA B44 ANTIGEN;

ALLELE; ARTICLE; EMBRYO; GENETIC POLYMORPHISM; HLA MATCHING; HUMAN; HUMAN CELL; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO ACIDS; BINDING SITES; HEK293 CELLS; HLA-B44 ANTIGEN; HUMANS; LEUCINE; MODELS, MOLECULAR; PEPTIDES; PHENYLALANINE; POLYMORPHISM, GENETIC; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY;

EID: 84866731288     PISSN: 00937711     EISSN: 14321211     Source Type: Journal    
DOI: 10.1007/s00251-012-0625-1     Document Type: Article

References (24)

1. *44:02P. Hum Immunol 72:1039-1044
2. *74 generates C-terminal promiscuity among its bound peptides. Tissue Antigens 78:378-81
3. *41 variants. Immunogenetics 59:253-259
4. *6601 ligands. Immunogenetics 56:83-88
5. *44: 08. Immunogenetics 64:245-9
6. *44 allotypes. Haematologica 97:98-106
7. Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, Williams AF, Ziegler A (1978) Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 14:9-20
8. Belich MP, Trowsdale J (1995) Proteasome and class I antigen processing and presentation. Mol Biol Rep 21:53-6
9. Blanco-Gelaz MA, Suarez-Alvarez B, Diaz-Pena R, Lopez-Larrea C (2009) HLA-B27 polymorphism at position 116 critically influences the association with TAP/tapasin, intracellular trafficking and conformational homodimers formation. Mol Immunol 46:1304-11
10. Brodsky FM, Parham P, Barnstable CJ, Crumpton MJ, Bodmer WF (1979) Monoclonal antibodies for analysis of the HLA system. Immunol Rev 47:3-61
11. Chelvanayagam G (1996) A roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities. Immunogenetics 45:15-26
12. *0302 located outside the pocket F alters the POmega peptide motif. Tissue Antigens 76:487-90
13. Fleischhauer K, Kernan NA, O'Reilly RJ, Dupont B, Yang SY (1990) Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med 323:1818-22
14. Frahm N, Yusim K, Suscovich TJ, Adams S, Sidney J, Hraber P, Hewitt HS, Linde CH, Kavanagh DG, Woodberry T, Henry LM, Faircloth K, Listgarten J, Kadie C, Jojic N, Sango K, Brown NV, Pae E, Zaman MT, Bihl F, Khatri A, John M, Mallal S, Marincola FM, Walker BD, Sette A, Heckerman D, Korber BT, Brander C (2007) Extensive HLA class I allele promiscuity among viral CTL epitopes. Eur J Immunol 37:2419-33
15. Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18:2714-23
16. Hillen N, Mester G, Lemmel C, Weinzierl AO, Muller M, Wernet D, Hennenlotter J, Stenzl A, Rammensee HG, Stevanovic S (2008) Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA-B44 supertype. Eur J Immunol 38:2993-3003
17. Hirosawa M, Hoshida M, Ishikawa M, Toya T (1993) MASCOT: multiple alignment system for protein sequences based on threeway dynamic programming. Comput Appl Biosci 9:161-7
18. Lemmel C, Weik S, Eberle U, Dengjel J, Kratt T, Becker HD, Rammensee HG, Stevanovic S (2004) Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling. Nat Biotechnol 22:450-4
19. Macdonald WA, Chen Z, Gras S, Archbold JK, Tynan FE, Clements CS, Bharadwaj M, Kjer-Nielsen L, Saunders PM, Wilce MC, Crawford F, Stadinsky B, Jackson D, Brooks AG, Purcell AW, Kappler JW, Burrows SR, Rossjohn J, McCluskey J (2009) T cell allorecognition via molecular mimicry. Immunity 31:897-908
20. Macdonald WA, Purcell AW, Mifsud NA, Ely LK, Williams DS, Chang L, Gorman JJ, Clements CS, Kjer-Nielsen L, Koelle DM, Burrows SR, Tait BD, Holdsworth R, Brooks AG, Lovrecz GO, Lu L, Rossjohn J, McCluskey J (2003) A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition. J Exp Med 198:679-91
21. Peh CA, Burrows SR, Barnden M, Khanna R, Cresswell P, Moss DJ, McCluskey J (1998) HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity 8:531-42
22. Rao X, Hoof I, Costa AI, van Baarle D, Kesmir C (2011) HLA class I allele promiscuity revisited. Immunogenetics 63:691-701
23. Saper MA, Bjorkman PJ, Wiley DC (1991) Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol 219:277-319
24. Theodossis A, Guillonneau C, Welland A, Ely LK, Clements CS, Williamson NA, Webb AI, Wilce JA, Mulder RJ, Dunstone MA, Doherty PC, McCluskey J, Purcell AW, Turner SJ, Rossjohn J (2010) Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition. Proc Natl Acad Sci U S A 107:5534-9